Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2026-09-15 21:38:58 ET · period of report 2026-09-11 · accession 0001871714-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-15 21:38 | 2026-09-11+ | TENX | Giordano Christopher Thomas | CEO, Dir | P - Purchase | $1.85 | +10.8K | 22.2K | +96% | +$20.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | P | A | 6,000 | $1.88 | 17,324 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.87 to $1.88. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2026-09-15 | P | A | 4,850 | $1.82 | 22,174 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $1.82 to $1.83. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |